Thu, Oct 23, 2014, 6:29 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Pacific Biosciences of California, Inc. Message Board

  • nimuma nimuma Sep 23, 2013 11:06 PM Flag

    PacBio executives sit quietly as territory invaded by "potential" new technology

    The peril of having a veteran scientist as the CEO manifest in PacBio's daily business. Hunkapilla, clearly lacking business vision, is going to drive pacbio down to abysmal ending.

    After oxford nanopore. Genia came to the center stage, touting commercial launch in late 2014. Real or not, these fancy claims would hold people back from ordering sequencers from PacBio.

    Long read is not everything. It is not even needed for most sequencing applications. The bad news for PACB investors is Hunkapilla clearly has no viable solutions to push throughput and accuracy up, and reduce instrument cost.

    This guy bought a #$%$ load of stocks above 5 dollars before he became the CEO. I hope he knows what he is doing, not by blind arrogance and naive confidence.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • What's his salary for 2013 ?

      This company will be get sold... and hopefully before the end of the year.

      Good luck... or good riddance.

      • 2 Replies to waiting4kerx
      • It could be a blessing to all the investors if PACB got bought before the end of the year. But if the executives think themselves can turn this thing around singlehandedly, they will not work hard on a M&A. Unfortunately they are usually overestimating their business capability.

      • Here... I'll save you the trouble of looking it up yourself.

        The CEO will be working for $1 (salary) in 2013 and has PURCHASED 1.5M shares at an average cost of $1.81 since 8-9-2011 and he hasn't sold a single share.

        Just consider that he bought 100K shares in 2011 at an average cost of $5.77. What does he know that you and I don't? He has a track record of selling companies and making big $ which is why I bought and will hold this company long term.

        03-Dec-12 56,700 PACB Purchase at $1.75 per share.(Cost of $99,225)
        30-Nov-12 97,400 PACB Purchase at $1.76 per share.(Cost of $171,424)
        29-Nov-12 97,400 PACB Purchase at $1.74 per share.(Cost of $169,476)
        28-Nov-12 97,400 PACB Purchase at $1.68 per share.(Cost of $163,632)
        27-Nov-12 47,400 PACB Purchase at $1.55 per share.(Cost of $73,470)
        26-Nov-12 97,400 PACB Purchase at $1.49 per share.(Cost of $145,126)
        23-Nov-12 50,000 PACB Purchase at $1.45 per share.(Cost of $72,500)
        21-Nov-12 39,000 PACB Purchase at $1.32 per share.(Cost of $51,480)
        20-Nov-12 65,600 PACB Purchase at $1.27 per share.(Cost of $83,312)
        19-Nov-12 89,400 PACB Purchase at $1.26 per share.(Cost of $112,644)
        16-Nov-12 100,000 PACB Purchase at $1.21 per share.(Cost of $121,000)
        15-Nov-12 150,000 PACB Purchase at $1.12 per share.(Cost of $168,000)
        14-Nov-12 12,300 PACB Purchase at $1.13 per share.(Cost of $13,898)
        07-Aug-12 347,500 PACB Purchase at $1.75 per share.(Cost of $608,125)
        06-Aug-12 52,500 PACB Purchase at $1.75 per share.(Cost of $91,875)
        10-Aug-11 30,000 PACB Purchase at $5.68 per share.(Cost of $170,400)
        09-Aug-11 70,000 PACB Purchase at $5.81 per share.(Cost of $406,700)

        I bought my shares at $1.57... think I'm doing o.k.?

        : )

 
PACB
5.66+0.23(+4.24%)Oct 23 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.